홈 › 유방암 › 일리노이

일리노이의 유방암 임상 시험

유방암 관련 연구 81개가 일리노이 내 여러 지역에서 참여자를 모집하고 있습니다.

일리노이의 도시

공식 연구 텍스트(영어)

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

University of Illinois at Chicago, Chicago
NorthShore University Health System - Evanston Hospital, Evanston
Duly Health and Care, Lisle
외 2개

피험자 모집 중1상

18세 ~ 55세 · 여성 · 2026. 11. 12. 업데이트됨 · NCT07310420

Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)

Orchard Healthcare Research Inc. ( Site 0006), Skokie

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT06797635

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

John H Stroger Jr Hospital of Cook County, Chicago
Decatur Memorial Hospital, Decatur
Loyola University Medical Center, Maywood
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 12. 업데이트됨 · NCT03418961

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

University of Illinois Hospital & Health Sciences System, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06827236

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Southern Illinois Hospital Services ( Site 9554), Carterville

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 10. 업데이트됨 · NCT06966700

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

City of Hope Chicago, Zion

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07007559

BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer

University of Illinois Cancer Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT04891068

Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)

University of Illinois, Chicago

피험자 모집 중4상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT06169371

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

City of Hope® Cancer Center Chicago, Zion

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT03424005

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Orchard Healthcare Research Inc.- Skokie, Skokie

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06324357

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Northwestern University, Chicago

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07214532

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

Northwestern University, Chicago

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT05315700

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

Rush University Medical Center, Chicago
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT06982521

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

City of Hope, Chicago, Chicago
Northwestern Memorial Hospital, Chicago
University of Illinois at Chicago, Chicago
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07174336

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Cancer Care Specialists of Central Illinois, O'Fallon
Springfield Clinic, Springfield
Carle Cancer Center, Urbana
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06790693

E-Mindfulness Approaches for Living After Breast Cancer

Northwest Community Hospital, Arlington Heights
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
외 55개

피험자 모집 중3상

18세 ~ 50세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06748222

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

City of Hope, Chicago, Chicago

피험자 모집 중2상

18세 이상 · 여성 · 2026. 11. 4. 업데이트됨 · NCT07287098

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

OSF Saint Anthony's Health Center, Alton
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
외 52개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT05334069

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

OSF Saint Anthony's Health Center, Alton
Rush-Copley Medical Center, Aurora
Advocate Outpatient Center - Aurora, Aurora
외 45개

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06418204

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

OSF Saint Anthony's Health Center, Alton
Advocate Outpatient Center - Aurora, Aurora
Advocate Good Shepherd Hospital, Barrington
외 83개

피험자 모집 중3상

18세 ~ 60세 · 여성 · 2026. 11. 4. 업데이트됨 · NCT05879926

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

Cancer Care Specialists, Decatur
Cancer Care Specialists of Illinois, O'Fallon
Carle Foundation Hospital d/b/a Carle Cancer Center, Urbana

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07173751

Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Northshore University Health System, Evanston

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT05974150

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

The University of Chicago Medical Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07102381

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

City of Hope, Chicago, Zion

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 28. 업데이트됨 · NCT07109726

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Rush Cancer Center, Chicago

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT06401421

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

University of Illinois Cancer Center, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT06172478

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

City of Hope® Cancer Center Chicago, Zion

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 26. 업데이트됨 · NCT07100106

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

Carle Health, Urbana

피험자 모집 중

21세 이상 · 여성 · 2026. 10. 22. 업데이트됨 · NCT05484973

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Research Site, Evanston

피험자 모집 중3상

18세 ~ 130세 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07647328

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Endeavor Health Cancer Institute at Swedish Hospital, Nancy W. Knowles Cancer Center, Elmhurst
Prime Saint Francis-Infusion Services Evanston, Evanston
Hope and Healing Clinical Research LLC, Hinsdale
외 8개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 19. 업데이트됨 · NCT07062965

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

University of Illinois Cancer Center, Chicago
University of Chicago Medicine, Chicago
City of Hope - Chicago, Zion

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06293898

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Rush University Medical Center ( Site 0079), Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 13. 업데이트됨 · NCT06312176

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

Carle Cancer Center, Urbana

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 10. 9. 업데이트됨 · NCT05386108

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Research Site, Chicago

피험자 모집 중1/2상

18세 ~ 130세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05417594

A Study of PHST001 in Advanced Solid Tumors

University of Chicago Medical Center, Chicago

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT06840886

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

University of Illinois Cancer Center, Chicago
The University of Chicago, Chicago

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06369285

PRE-ISPY Phase I/II Oncology Platform Program

The University of Chicago Medicine Comprehensive Cancer Center, Chicago
UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
UChicago Medicine Orland Park, Orland Park

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT05868226

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Northwestern Medicine Chicago Proton Center, Warrenville

피험자 모집 중2상

50세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT01766297

Study to Understand Relationship Between Gut Health and Toxicities of Hormonal Breast Cancer Treatment

The University of Chicago Medicine Comprehensive Cancer Center, Chicago

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07553234

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

Research Site, Chicago

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864

ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.